#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chemical burn Warm autoimmune haemolytic anaemia Cutaneous T-cell lymphoma stage II Anti-neutrophil cytoplasmic antibody positive vasculitis Follicular lymphoma stage III Small for dates baby Hepatitis B Extra-osseous Ewing's sarcoma metastatic Cholangiosarcoma Brain injury Eosinophilic granulomatosis with polyangiitis Hereditary angioedema Haemophilia A with anti factor VIII Haemophilia B with anti factor IX Mucopolysaccharidosis III More trials…

    Learn about Rare Diseases

    X-linked lymphoproliferative syndrome – Basic Information Osteosarcoma metastatic – Treatment Myelodysplastic syndrome with excess blasts Encephalitis autoimmune – Life with Disease Lennox-Gastaut syndrome – Trials in Disease Familial haemophagocytic lymphohistiocytosis – Basic Information Pleural mesothelioma malignant – Life with Disease Carcinoid syndrome – Life with Disease Mantle cell lymphoma – Treatment Leukoencephalopathy – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Aup1602-C Quercus Ilex Allergen Extract Natalizumab Golcadomide Mps-103 Alks 2680 Avutometinib Namodenoson 4-Hydroxy-N-Desmethyltamoxifen Meropenem Anhydrous TROFOLASTAT STREPTOCOCCUS VIRIDANS Gentamicin Sulfate Testosterone Undecanoate Itraconazole Lidocaine Dermatophagoides Farinae Liraglutide Palonosetron Neflamapimod More therapies…

    Learn about Your Condition

    Brain abscess Myelodysplastic syndrome Cholangiosarcoma Bone sarcoma Staphylococcal bacteraemia Cleft lip and palate Ligament operation Ichthyosis Endocarditis bacterial Gaucher's disease type I Meningioma Dengue fever Chondrosarcoma Cardiovascular disorder Meningioma malignant More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Long-Term Safety and Efficacy Study of Eplontersen in Patients with Hereditary Transthyretin-Mediated Amyloid Polyneuropathy

    Recruiting

    3 1 1
    Investigated Drugs:
    • Eplontersen
    Cyprus France Germany Italy Portugal Spain +1

  • Study on Sotagliflozin for Slowing Kidney Disease in Type 1 Diabetes Patients

    Recruiting

    2 1 1
    Investigated Diseases:
    • Type 1 diabetes mellitus
    Investigated Drugs:
    • Sotagliflozin
    Denmark

  • Study on Long-Term Safety of Ranibizumab for Patients with Wet Age-Related Macular Degeneration Using a Port Delivery System

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Neovascular age-related macular degeneration
    Investigated Drugs:
    • Ranibizumab
    Austria Belgium France Germany Italy Spain

  • Study of Fertility Preservation Using Tamoxifen, Follitropin Beta, Cetrorelix and Choriogonadotropin Alfa in Women with Breast Cancer Before Chemotherapy

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Cetrorelix
    • Follitropin Beta
    • Choriogonadotropin Alfa
    France

  • Study of oxycodone safety and effectiveness for pain relief during labor and its effects on newborns

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Labour pain
    Investigated Drugs:
    • Oxycodone Hydrochloride Trihydrate
    Finland

  • Study on the Effects of Low-Dose Acetylsalicylic Acid in Patients with Bipolar Disorder

    Recruiting

    2 1 1
    Investigated Diseases:
    • Bipolar disorder
    Investigated Drugs:
    • Acetylsalicylic Acid
    Poland
Previous Page
1 … 334 335 336 337 338 … 1,650
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!